JIMMY BOYD: Open Payments
NPI 1396745584 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 100 payments from 15 companies in 2025. Trend: 2023 $448 · 2024 $184 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $648 |
| SK Life Science, Inc. | 10 | $303 |
| Lundbeck LLC | 11 | $163 |
| Lilly USA, LLC | 6 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $113 |
| Eisai Inc. | 4 | $93 |
| ACADIA Pharmaceuticals Inc | 4 | $86 |
| UCB, Inc. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 2 | $45 |
Products named: BOTOX, UBRELVY, VYEPTI, QULIPTA, VYALEV, KESIMPTA, Leqembi, NUPLAZID.
Industry payments across AL — which companies pay providers there.
